A listing of recent antidumping and countervailing duty messages from the Commerce Department posted to CBP's website May 22, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at http://adcvd.cbp.dhs.gov/adcvdweb.
Members of the trade community recommended that CBP work toward an automated system that would allow greater control over the right to make entry, at a meeting of the Advisory Committee on Commercial Operations (COAC) held May 22 in Miami. That would help address enforcement issues related to identity theft and, combined with additional data requirements and automation for CBP Form 5106, would replace an earlier idea that changes be made to Part 111 broker regulations related to powers of attorney. CBP officials attending the meeting praised the suggestion of an automated system, with an official involved in the development of the Automated Commercial Environment (ACE) saying similar capabilities are already in place.
The Fish and Wildlife Service recently announced two administrative actions related to rules on trade in elephant ivory. The agency on May 15 revised a Director’s Order to allow for the international transportation of certain musical instruments containing African elephant ivory, as well as the importation of museum items containing ivory. It also announced a final rule to “reduce the regulatory impact on the public” of the “use after import” requirement for elephant ivory.
The International Trade Commission published notices in the May 22 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the May 22 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
Consumer Product Safety Commission announced on May 21 the following voluntary recalls of imported products:
On May 21 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for May 21 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.
The Food and Drug Administration said it may refuse imports from pharmaceutical manufacturers in India and Germany, in separate warning letters sent to the companies in April and May. FDA said an inspection of a Sun Pharmaceutical Industries manufacturing facility in Gujarat, India turned up violations of CGMP requirements for both finished pharmaceuticals and active pharmaceutical ingredients (APIs) (here). It also told SANUM-Kehlbeck that an inspection of the pharmaceutical manufacturer’s facility in Hoya, Germany found violations of CGMP requirements for both finished pharmaceuticals and APIs, as well as a failure by the company to register with FDA (here). The agency told both companies that their drug products are subject to refusal of admission because of the violations.
The Food and Drug Administration told a fish importer that it may begin refusing admission to its products because of violations of hazard analysis and critical control point (HACCP) and acidified food regulations. In a warning letter dated May 13, FDA said Ridgewood, New York-based Maharaja Foods Importers failed to take steps to ensure its shelf stable glass-packed pickled tuna in oil complies with HACCP requirements. The agency also said that an inspection of an entry of Maharaja’s pickled tuna revealed that the foreign exporter didn’t register as an acidified food manufacturer. FDA said that, unless corrected, it may begin refusing shipments imported by Maharaja at the border. It also said it may collect fees to cover the costs of reinspection.